SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001213900-21-061618
Filing Date
2021-11-23
Accepted
2021-11-23 16:36:28
Documents
48
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-Q f10q0921a1_fsdevel2.htm   iXBRL 10-Q/A 560263
2 CERTIFICATION f10q0921a1ex31-1_fsdevelop2.htm EX-31.1 10817
3 CERTIFICATION f10q0921a1ex31-2_fsdevelop2.htm EX-31.2 10595
4 CERTIFICATION f10q0921a1ex32-1_fsdevelop2.htm EX-32.1 4717
5 CERTIFICATION f10q0921a1ex32-2_fsdevelop2.htm EX-32.2 4514
  Complete submission text file 0001213900-21-061618.txt   3700481

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE fsii-20210930.xsd EX-101.SCH 34236
7 XBRL CALCULATION FILE fsii-20210930_cal.xml EX-101.CAL 19442
8 XBRL DEFINITION FILE fsii-20210930_def.xml EX-101.DEF 173307
9 XBRL LABEL FILE fsii-20210930_lab.xml EX-101.LAB 281260
10 XBRL PRESENTATION FILE fsii-20210930_pre.xml EX-101.PRE 177773
11 EXTRACTED XBRL INSTANCE DOCUMENT f10q0921a1_fsdevel2_htm.xml XML 640615
Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111 415 877 4887
FS Development Corp. II (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40067 | Film No.: 211439014
SIC: 2834 Pharmaceutical Preparations